Outcome events | Unadjusted analyses | Adjusted analyses* | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Outcome | Exposure (indicator met) | N | Exposed group | Unexposed group | HR | 95% CI | p | HR | 95% CI | p |
Retinopathy | HbA1c | 37,182 | 2575 | 2897 | 0.87 | 0.83–0.92 | < 0.0001 | 0.94 | 0.89–0.99 | 0.0300 |
Blood pressure | 50,426 | 3291 | 3721 | 0.88 | 0.84–0.92 | < 0.0001 | 0.87 | 0.83–0.92 | < 0.0001 | |
Cholesterol | 30,978 | 2164 | 2018 | 1.01 | 0.95–1.08 | 0.6988 | 1.03 | 0.97–1.10 | 0.2918 | |
All QOF indicators | 40,220 | 2402 | 2773 | 0.84 | 0.80–0.89 | < 0.0001 | 0.86 | 0.81–0.91 | < 0.0001 | |
Sight-threatening retinopathy | HbA1c | 37,182 | 235 | 370 | 0.66 | 0.56–0.78 | < 0.0001 | 0.74 | 0.62–0.87 | 0.0002 |
Blood pressure | 50,426 | 296 | 400 | 0.79 | 0.68–0.92 | 0.0022 | 0.78 | 0.67–0.91 | 0.0015 | |
Cholesterol | 30,978 | 200 | 224 | 0.80 | 0.66–0.97 | 0.0249 | 0.82 | 0.67–0.99 | 0.0428 | |
All QOF indicators | 40,220 | 191 | 249 | 0.75 | 0.62–0.90 | 0.0023 | 0.77 | 0.64–0.93 | 0.0065 |